Alumis Inc. Common Stock
HealthcareNASDAQ:ALMS · NASDAQ Global Select
+$3.25 today
Vol 2.22M · Avg 1.30M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+669.11%
Period High
$29.98
Period Low
$2.80
Latest
$24.15
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
RAPT Therapeutics, Inc.
RAPT
$959.26M
Eton Pharmaceuticals, Inc.
NASDAQ:ETON
$865.32M
Lexicon Pharmaceuticals, Inc.
NASDAQ:LXRX
$852.86M
Omeros Corporation
NASDAQ:OMER
$632.20M
Ocugen, Inc.
NASDAQ:OCGN
$409.61M
Neumora Therapeutics, Inc. Common Stock
NASDAQ:NMRA
$329.81M
Lineage Cell Therapeutics, Inc.
AMEX:LCTX
$316.61M
Bicycle Therapeutics plc
NASDAQ:BCYC
$281.05M
Fulcrum Therapeutics, Inc.
NASDAQ:FULC
$186.68M
ADC Therapeutics S.A.
NYSE:ADCT
$133.55M
What is the latest ALMS filing?
The latest filing shown is 4 dated May 27, 2026.
How many recent filings does ALMS have?
Intrinsic Alpha currently shows 20 recent filings for ALMS.
Explore More
Continue the stock analysis
Jump to another research area for this company.